Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L13a pseudogene 24 (RPL13AP24)
- Target
- RPL13AP24
- Molecular classification
- Pseudogene, Other
01
Overview
**Ribosomal protein L13a pseudogene 24** (RPL13AP24) is classified as a pseudogene, meaning it is a DNA sequence similar to a functional gene (RPL13A) but does not encode a functional protein due to mutations or loss of regulatory elements[1][4][6][8][10]. It is one of many processed pseudogenes dispersed throughout the human genome that originate from the protein-coding gene RPL13A, which encodes a structural component of the ribosomal 60S subunit[3][5]. Unlike the functional gene, RPL13AP24 is not known to produce protein or possess a therapeutic or physiological role. Pseudogenes can complicate genetic studies due to their sequence similarity with functional genes[10], but there is no evidence that RPL13AP24 itself is implicated in disease, functions as a biomarker, or is a target of any known drugs.
- Other names
- RPL13A_8_1193ribosomal protein L13a pseudogene 24
02
Biological functions
Other (pseudogenes do not encode functional proteins and generally do not have biological functions themselves)
03
Disease associations
Other (no evidence for a disease role for this specific pseudogene)
Beyond the preview
Go deeper on Ribosomal protein L13a pseudogene 24 (RPL13AP24).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L13a pseudogene 24 (RPL13AP24).